Measles Exposure Reported at Philadelphia International Airport
Health officials are investigating a potential measles exposure at Philadelphia International Airport, marking the second such incident in the city within a week.
Philadelphia health officials have reported a potential measles exposure at Philadelphia International Airport, affecting terminals B and F, as well as connecting areas in C, D, and E. The exposure is believed to have occurred between Sunday, September 13, and the early hours of Monday, September 14. The individual diagnosed with measles was traveling through the airport and did not leave the premises.
This incident follows a previous measles exposure reported on September 17 at the Children’s Hospital of Philadelphia (CHOP). The Philadelphia Department of Public Health is urging individuals who may have been exposed to check their vaccination status and monitor for symptoms.
Response and Recommendations
In response to the CHOP exposure, health departments in Pennsylvania and Philadelphia, along with CHOP, stated they are working together to provide preventative antibody treatments to potentially exposed infants. Health Commissioner Dr. Palak Raval-Nelson emphasized the importance of vaccination, noting that "Every Philadelphian who is fully vaccinated has little to fear from the situation at CHOP and the airport." She added that vaccinations protect the most vulnerable populations.
The health department advises individuals who were exposed and are not immune, unsure of their vaccination status, infants, pregnant individuals, or those who are immunocompromised to contact their doctor. They also recommend that anyone developing measles symptoms should call healthcare facilities ahead of their visit and disclose the potential exposure.
Measles Outbreak Context
In August, Pennsylvania confirmed two measles-related deaths, the first such fatalities in the state in 35 years. Both individuals were unvaccinated. The MMR vaccine, administered in two doses, provides approximately 97% lifetime protection against measles, according to health officials.
Measles is a highly contagious respiratory virus that can be fatal in a small percentage of cases. Complications can include pneumonia and brain swelling, with nearly 20% of infected individuals requiring hospitalization. Early symptoms, appearing seven to 21 days after exposure, include fever, cough, runny nose, and red, watery eyes, followed by a rash that typically starts on the head and spreads downwards.